Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

agaricoglyceride A

 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Glycerides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Peptidase neurolysin functions to preserve the brain after ischemic stroke in male mice
Previous studies documented up‐regulation of peptidase neurolysin (Nln) after brain ischemia, however, the significance of Nln… Expand
Is this relevant?
2015
2015
Statistical Optimization of the Content Composition Precursors Using Response Surface Methodology to Enhance Agaricoglyceride A Production from the Shaggy Ink Cap Medicinal Mushroom, Coprinus comatus…
Coprinus comatus, a novel cultivated edible mushroom, has a various of pharmacological effects due to its many active components… Expand
Is this relevant?
Review
2013
Review
2013
The analgesic effect of several edible mushrooms
Introduction Edible mushrooms, a valuable source of bioactive compounds and nutrients, have been consumed as part of the diet in… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
Is this relevant?
2011
2011
Improving Oral Bioavailability of Agaricoglycerides by Solid Lipid-Based Self-Emulsifying Drug Delivery System
Agaricoglyceride A (AGA), showed strong activities against neurolysin. The objectives of this study was to prepare solid self… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
2005
2005
Novel Analgesic Triglycerides from Cultures of Agaricus macrosporus and Other Basidiomycetes as Selective Inhibitors of Neurolysin
The agaricoglycerides are a new class of fungal secondary metabolites that constitute esters of chlorinated 4-hydroxy benzoic… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE